Amy Peterson

Amy Peterson

Company: CytomX

Job title: Executive Vice President & Chief Development Officer


Reinventing Therapeutic Antibody Drug Conjugates for the Treatment of Cancer 3:00 pm

Typical approach to ADC development in oncology and limitations What does undruggable mean in oncology? The CytomX Probody® platform and why/how it can be applied to antibodies and ADCs Non-clinical and clinical data validating that the Probody platform works as designed Future applications of Probody technology to other modalities: Cytokines, Agonistic Antibodies, T-cell BispecificsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.